SALT LAKE CITY, Feb. 02, 2023 (GLOBE NEWSWIRE) — LifeVantage Corporation LFVN announced today that the Company’s Board of Directors has approved a quarterly cash dividend of $0.03 per common share to be paid on March 15, 2023 to all shareholders of record at the close of business on March 1, 2023.

About LifeVantage Corporation

LifeVantage Corporation LFVN is a pioneer in nutrigenomics, the study of how diet and naturally occurring compounds influence human genes to support good health. The Company is engaged in the identification, research, development, formulation and sale of advanced nutrigenomic activators, nutritional supplements, nootropics, pre- and probiotics, weight management, skin and hair care, bath and body, and targeted relief products. The company’s scientifically validated supplements include its flagship product, Protandim^® Product family LifeVantage^® Omega+™, ProBio™, IC Bright^®and Daily Wellness™ nutritional supplements, the TrueScience^® Skin, hair, bath and body line as well as targeted relief products. The company also markets and sells petandim^®its pet supplement for fighting oxidative stress in dogs, Axio^® its nootropic energy drink blends and PhysIQ™, its intelligent weight management system. Founded in 2003, LifeVantage is headquartered in Lehi, Utah. For more information visit www.lifevantage.com.

Cautionary Note Regarding Forward-Looking Statements

This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions that reflect optimism, satisfaction, or disappointment about current prospects, such as “believe”, “will”, “hope”, “intend”, “estimate”, “expect”, “project”, “plan”, “Anticipate,” “look forward to,” “goal,” “may be,” and variations thereof identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. The…